DirectorBlood Transfusion Centre, National Reference Centre for Congenital Bleeding Disorders, Laiko General HospitalAthens, Attiki, Greece
PB0186 - Results from BeneGene-1 Study: Prospective collection of bleeding rate in hemophilia B patients prior to phase 3 study (BeneGene-2) of fidanacogene elaparvovec
Sunday, June 25, 202318:30 – 19:30 ET
OC 52.3 - Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial
Tuesday, June 27, 202311:15 – 11:30 ET
PB1296 - A prospective, non-interventional study to investigate the effectiveness of rVIII-SingleChain in patients with hemophilia A
Tuesday, June 27, 202318:30 – 19:30 ET
